GeoVX Shares Plunge 15.15% to 2024 Lows Amid Sector Pressures, No Near-Term Catalysts

The share price fell to its lowest level since January 2024 today, with an intraday decline of 15.15%.

The recent selloff has seen GeoVax Labs (GOVX) shares drop 30.51% over the past six trading days, marking a six-day losing streak. The decline brought the stock to levels not seen since early 2024, despite the absence of material corporate or market catalysts to explain the selloff.

Analysts note that the lack of near-term clinical trial data, partnership announcements, or regulatory updates has left investors without clear guidance, contributing to the prolonged downward trend.

Broader market dynamics, including sector-specific pressures and macroeconomic concerns, may have exacerbated the sell-off. However, the stock’s performance remains decoupled from company-specific developments, as no significant operational or financial updates have been disclosed to impact investor sentiment. With no immediate catalysts on the horizon, the stock could remain volatile as investors await clarity on the company’s strategic direction and pipeline progress.